Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
about
Bezlotoxumab: Could This be the Answer for Clostridium difficile Recurrence?Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection.Emerging monoclonal antibodies against Clostridium difficile infection.Bezlotoxumab for the prevention of Clostridium difficile recurrence.Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Editorial Commentary: Where to Place the New Treatments for Clostridium difficile Infection?A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia.Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection.Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.An Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection.Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
P2860
Q38686710-38428B1F-0B72-421F-A24F-CD1FD8B43564Q38755888-999A4266-656B-4D12-974B-5BFFF5AE2D37Q39145792-1AEB4AE2-E766-4412-A4CC-9791BFC41535Q39168914-42A7F9AF-D2EB-4636-B409-43CE79FFFC97Q40095035-CA7EDC40-A219-49BC-AADD-B73C82F32995Q40125340-03C3D600-62E4-4E9F-A0FA-960D1AFCEF0BQ40233875-9DFC24F8-CEDB-4D60-B20D-7EC9FAA0834AQ41996759-E45F5BD7-28A1-4B3D-AB3A-3D55E5E06371Q42336377-F6069F8C-F07F-4D92-A80C-58DA175F65BBQ48174220-D34DC7E3-962A-4800-83DE-A4CC4E8F2834Q49201152-318CADC4-11E1-4B69-BA90-F3A0113365C9Q55103812-CFA88B45-CB13-497C-BB13-3191BF15644EQ55220241-3E3F83EA-7C87-4A4C-8028-FF051A516197Q57455315-1933316D-D741-4643-8D31-F97E9E44E7EC
P2860
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@en
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@nl
type
label
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@en
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@nl
prefLabel
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@en
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@nl
P2093
P2860
P356
P1476
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
@en
P2093
Dalya Guris
Deborah Molrine
Marilyne Dupin
Mark Leney
Mark Miller
Mary Beth Dorr
Swati B Gupta
T Christopher Mast
Vinay Mehta
Xuemei Zhao
P2860
P304
P356
10.1093/CID/CIW364
P407
P577
2016-06-30T00:00:00Z